Undertreatment of congestive heart failure in an Australian setting

Journal of Clinical Pharmacy and Therapeutics

Volumn 29, Issue 1, 2004, Pages 15-22

  Boyles, P J ^a   Peterson, G M ^a   Bleasel, M D ^b   Vial, J H ^c  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ROYAL HOBART HOSPITAL   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

blockers; Angiotensin converting enzyme inhibitors; Congestive heart failure; Drug therapy; Spironolactone

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; AUSTRALIA; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DOSE RESPONSE; FEMALE; GOOD CLINICAL PRACTICE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRACTICE GUIDELINE; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; WARD;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AUSTRALIA; DIURETICS; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE, CONGESTIVE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES;

EID: 1342267658     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2003.00531.x     Document Type: Article

References (49)

1. Ahmed A (2003) American College of Cardiology/American Heart Association chronic heart failure evaluation and management guidelines: relevance to the geriatric practice. Journal of the American Geriatrics Society, 51, 123-126.
2. Lloyd-Jones DM (2001) The risk of congestive heart failure: sobering lessons from the Framingham Heart Study. Current Cardiology Reports, 3, 184-190.
3. Krum H, National Heart Foundation of Australia, Cardiac Society of Australia, New Zealand Chronic Heart Failure Clinical Practice Guidelines Writing Party (2001) Guidelines for management of patients with chronic heart failure in Australia. Medical Journal of Australia, 174, 459-466.
4. Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV (2002) Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Archives of Internal Medicine, 162, 1689-1694.
5. Jessup M, Brozena S (2003) Heart failure. New England Journal of Medicine, 348, 2007-2018.
6. Berry C, Murdoch DR, McMurray JJV (2001) Economics of chronic heart failure. European Journal of Heart Failure, 3, 283-291.
7. Eichhorn EJ (1998) Our new understanding of heart failure: the role of beta-blockers in treatment. Cleveland Clinic Journal of Medicine, 65, 428-435.
8. Remme WJ, Swedberg K (2002) Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. European Journal of Heart Failure, 4, 11-22.
9. Hunt SA, Baker DW, Chin MH et al. (2002) ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. Journal of Heart and Lung Transplantation, 21, 189-203.
10. Shetty K (2002) Chronic heart failure guidelines. European Heart Journal, 23, 425-426.
11. Cardiovascular Guidelines Sub-Committee (1999) Therapeutic guidelines: cardiovascular version 3. Melbourne: Therapeutic Guidelines Inc.
12. Hobbs FDR, Davis RC, Lip GYH (2000) ABC of heart failure: heart failure in general practice. British Medical Journal, 320, 626-629.
13. Watson RDS, Gibbs CR, Lip GYH (2000) ABC of heart failure: clinical features and complications. British Medical Journal, 320, 236-239.
14. Goff DC Jr, Pandey DK, Chan FA, Ortiz C, Nichaman MZ (2000) Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart Project. Archives of Internal Medicine, 160, 197-202.
15. Ahmed A, Allman RM, De Long JF, Bodner EV, Howard G (2002) Age-related underutilization of left ventricular function evaluation in older heart failure patients. Southern Medical Journal, 95, 695-702.
16. Dudley NJ, Bowling A, Bond M et al. (2002) Age- and sex-related bias in the management of heart disease in a district general hospital. Age and Ageing, 31, 37-42.
17. Cleland JG, Swedberg K, Follath F et al. (2003) The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. European Heart Journal, 24, 442-463.
18. Senni M, Rodeheffer RJ, Tribouilloy CM et al. (1999) Use of echocardiography in the management of congestive heart failure in the community. Journal of the American College of Cardiology, 33, 164-170.
19. Mejhert M, Holmgren J, Wandell P, Persson H, Edner M (1999) Diagnostic tests, treatment and follow-up in heart failure patients - is there a gender bias in the coherence to guidelines? European Journal of Heart Failure, 1, 407-410.
20. Burstein JM, Yan R, Weller I, Abramson BL (2003) Management of congestive heart failure: a gender gap may still exist. Observations from a contemporary cohort. BioMed Central Cardiovascular Disorders, 3, 1.
21. Komajda M, Follath F, Swedberg K et al. (2003) The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. European Heart Journal, 24, 464-474.
22. Bungard TJ, McAlister FA, Johnson JA, Tsuyuki RT (2001) Underutilisation of ACE inhibitors in patients with congestive heart failure. Drugs, 61, 2021-2033.
23. Stafford RS, Radley DC (2003) The underutilization of cardiac medications of proven benefit, 1990 to 2002. Journal of the American College of Cardiology, 41, 56-61.
24. Cline CM, Boman K, Holst M, Erhardt LR (2002) The management of heart failure in Sweden. European Journal of Heart Failure, 4, 373-376.
25. Muntwyler J, Follath F (2000) Medical treatment of heart failure: an analysis of actual treatment practices in outpatients in Switzerland. The Swiss "IMPROVEMENT of HF" Group. Schweizerische medizinische Wochenschrift, 130, 1192-1198.
26. Cleland JG, Cohen-Solal A, Aguilar JC et al. (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet, 360, 1631-1639.
27. Krum H, Tonkin AM, Currie R, Djundjek R, Johnston CI (2001) Chronic heart failure in Australian general practice - The Cardiac Awareness Survey and Evaluation (CASE) Study. Medical Journal of Australia, 174, 439-444.
28. Fuat A, Hungin AP, Murphy JJ (2003) Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. British Medical Journal, 326, 196.
29. Khunti K, Hearnshaw H, Baker R, Grimshaw G (2002) Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. European Journal of Heart Failure, 4, 771-777.
30. Krum H, Gilbert RE (2003) Demographics and concomitant disorders in heart failure. Lancet, 362, 147-158.
31. Krumholz HM, Wang Y, Parent EM, Mockalis J, Petrillo M, Radford MJ (1997) Quality of care for elderly patients hospitalized with heart failure. Archives of Internal Medicine, 157, 2242-2247.
32. Nilsson G, Strender LE (2002) Management of heart failure in primary health care. A retrospective study on electronic patient records in a registered population. Scandinavian Journal of Primary Health Care, 20, 161-165.
33. Ahmed A, Allman RM, DeLong JF, Bodner EV, Howard G (2002) Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients. Southern Medical Journal, 95, 703-710.
34. Pulignano G, Del Sindaco D, Tavazzi L et al. (2002) Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). American Heart Journal, 143, 45-55.
35. Agvall B, Dahlstrom U (2001) Patients in primary health care diagnosed and treated as heart failure, with special reference to gender differences. Scandinavian Journal of Primary Health Care, 19, 14-19.
36. Garcia Rodriguez LA, Hernandez-Diaz S (2003) Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure. Epidemiology, 14, 240-246.
37. Feenstra J, Heerdink ER, Grobbee DE, Stricker BH (2002) Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Archives of Internal Medicine, 162, 265-270.
38. Bleumink G, Feenstra J, Sturkenboom M, Stricker B (2003) Nonsteroidal anti-inflammatory drugs and heart failure. Drugs, 63, 525-534.
39. Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH, Bakker A (1998) NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Archives of Internal Medicine, 158, 1108-1112.
40. Page J, Henry D (2000) Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Archives of Internal Medicine, 160, 777-784.
41. Azevedo A, Pimenta J, Dias P, Bettencourt P, Ferreira A, Cerqueira-Gomes M (2002) Effect of a heart failure clinic on survival and hospital readmission in patients discharged from acute hospital care. European Journal of Heart Failure, 4, 353-359.
42. Kasper EK, Gerstenblith G, Hefter G et al. (2002) A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. Journal of the American College of Cardiology, 39, 471-480.
43. Krumholz HM, Amatruda J, Smith GL et al. (2002) Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. Journal of the American College of Cardiology, 39, 83-89.
44. McDonald K, Ledwidge M, Cahill J et al. (2002) Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care. Journal of Cardiac Failure, 8, 142-148.
45. Doughty RN, Wright SP, Pearl A et al. (2002) Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study. European Heart Journal, 23, 139-146.
46. Whellan DJ, Gaulden L, Gattis WA et al. (2001) The benefit of implementing a heart failure disease management program. Archives of Internal Medicine, 161, 2223-2228.
47. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM (1999) Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team - results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Archives of Internal Medicine, 159, 1939-1945.
48. Luzier AB, Forrest A, Feuerstein SG, Schentag JJ, Izzo JL Jr (2000) Containment of heart failure hospitalizations and cost by angiotensin- converting enzyme inhibitor dosage optimization. American Journal of Cardiology, 86, 519-523.
49. Pearson GJ, Cooke C, Simmons WK, Sketris I (2001) Evaluation of the use of evidence-based angiotensin-converting enzyme inhibitor criteria for the treatment of congestive heart failure: opportunities for pharmacists to improve patient outcomes. Journal of Clinical Pharmacy and Therapeutics, 26, 351-361.